30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Mustang Bio Inc (MBIO)

Track

The most recent insider trading activity occurred on December 30, 2025, with a buy transaction by Jin David and a sell transaction by Herskowitz Neil, both involving 247 shares. Prior to this, planned purchases were noted in September 2022. The last reported earnings date was May 11, 2026.
Stock chart
Ticker: MBIO Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Chill Adam J.
1 sale — total 4 USD
Sale 30 Dec 2025
Value US$1,291,688.94 | Price 369.08 | Shares 84,013
Sale 30 Dec 2025
Value US$4,781,138.76 | Price 233.90 | Shares 77,517
Buy 30 Dec 2025
Value US$237.61 | Price 0.96 | Shares 247
Planned buy 13 Sep 2022
Value US$2,582.00 | Price 0.52 | Shares 5,000
Planned buy 13 Sep 2022
Value US$2,582.00 | Price 0.52 | Shares 5,000
Planned buy 18 Mar 2022
Value US$3,025.47 | Price 0.74 | Shares 4,094
Planned buy 18 Mar 2022
Value US$3,695.00 | Price 0.74 | Shares 5,000
Sale 14 Dec 2021
Value US$8,004.42 | Price 1.83 | Shares 4,374
Buy 27 Oct 2021
Value US$145,600.00 | Price 2.24 | Shares 65,000
Sale 12 Oct 2021
Value US$10,146.00 | Price 2.28 | Shares 4,450
Sale 9 Apr 2021
Value US$8,141.28 | Price 3.36 | Shares 2,423
Buy 5 Mar 2021
Value US$516,553.44 | Price 3.12 | Shares 165,562
Buy 15 Dec 2020
Value US$291,000.00 | Price 2.91 | Shares 100,000
Buy 14 Dec 2020
Value US$266,000.00 | Price 2.66 | Shares 100,000
Sale 8 Dec 2020
Value US$15,710.55 | Price 3.03 | Shares 5,185
Sale 21 Oct 2020
Value US$9,076.32 | Price 2.97 | Shares 3,056
Buy 11 Jun 2020
Value US$499,999.50 | Price 3.25 | Shares 153,846
Sale 22 May 2020
Value US$25,377.92 | Price 3.04 | Shares 8,348
Sale 22 May 2020
Value US$12,236.00 | Price 3.04 | Shares 4,025
Sale 22 May 2020
Value US$2,675.20 | Price 3.04 | Shares 880
Buy 21 May 2020
Value US$281,700.00 | Price 3.13 | Shares 90,000
Buy 14 May 2020
Value US$251,100.00 | Price 2.79 | Shares 90,000
Sale 31 Mar 2020
Value US$8,007.12 | Price 2.64 | Shares 3,033
Sale 6 Dec 2019
Value US$22,671.36 | Price 3.69 | Shares 6,144
Buy 10 Dec 2018
Value US$26,804.80 | Price 3.35 | Shares 8,000
Buy 4 Dec 2018
Value US$27,000.00 | Price 3.60 | Shares 7,500
Buy 26 Nov 2018
Value US$19,353.50 | Price 3.87 | Shares 5,000
Buy 23 Nov 2018
Value US$3,960.00 | Price 3.96 | Shares 1,000
Buy 21 Nov 2018
Value US$21,048.00 | Price 4.21 | Shares 5,000
Buy 20 Nov 2018
Value US$9,720.25 | Price 3.89 | Shares 2,500
Buy 20 Nov 2018
Value US$1,937.10 | Price 3.87 | Shares 500
Buy 19 Nov 2018
Value US$4,250.00 | Price 4.25 | Shares 1,000
Buy 16 Nov 2018
Value US$4,310.00 | Price 4.31 | Shares 1,000
Buy 2 Nov 2018
Value US$220,500.00 | Price 4.41 | Shares 50,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-30 2025-12-30 S Sale
2.4
Chill Adam J.
Non-Executive Director
84,013 +42.7%
369.08
US$1,291,689 		84,013 +42.7% 369.08 US$1,291,689
2025-12-30 2025-12-30 S Sale
1.8
Herskowitz Neil
Non-Executive Director
77,517 -28.8%
233.90
US$4,781,139 		77,517 -28.8% 233.90 US$4,781,139
2025-12-30 2025-12-30 B Purchase
1.3
Jin David
Non-Executive Director
84,328 -48.5%
235.13
US$3,398,604 		84,328 -48.5% 235.13 US$3,398,604
2023-04-03 2022-09-13 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
5,000 +1.7%
0.52
US$2,582 		5,000 +1.7% 0.52 US$2,582
2023-04-03 2022-09-13 PP Planned purchase
3.1
Litchman Manuel MD
Non-Executive Director
5,000 +0.5%
0.52
US$2,582 		5,000 +0.5% 0.52 US$2,582
2023-04-03 2022-03-18 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
4,094 +1.9%
0.74
US$3,025 		4,094 +1.9% 0.74 US$3,025
2023-04-03 2022-03-18 PP Planned purchase
3.1
Litchman Manuel MD
Non-Executive Director
5,000 +0.5%
0.74
US$3,695 		5,000 +0.5% 0.74 US$3,695
2021-12-16 2021-12-14 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
4,374 -2.9%
1.83
US$8,004 		4,374 -2.9% 1.83 US$8,004
2021-11-08 2021-10-27 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
65,000 +6.7%
2.24
US$145,600 		65,000 +6.7% 2.24 US$145,600
2021-10-21 2021-10-12 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
4,450 -3.4%
2.28
US$10,146 		4,450 -3.4% 2.28 US$10,146
2021-04-16 2021-04-09 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
2,423 -1.8%
3.36
US$8,141 		2,423 -1.8% 3.36 US$8,141
2021-03-15 2021-03-05 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
165,562 +25.1%
3.12
US$516,553 		165,562 +25.1% 3.12 US$516,553
2020-12-22 2020-12-15 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
100,000 +18.0%
2.91
US$291,000 		100,000 +18.0% 2.91 US$291,000
2020-12-15 2020-12-14 B Purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
100,000 +99.6%
2.66
US$266,000 		100,000 +99.6% 2.66 US$266,000
2021-04-16 2020-12-08 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
5,185 -3.7%
3.03
US$15,711 		5,185 -3.7% 3.03 US$15,711
2021-04-16 2020-10-21 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
3,056 -2.2%
2.97
US$9,076 		3,056 -2.2% 2.97 US$9,076
2020-06-15 2020-06-11 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
153,846 +45.9%
3.25
US$500,000 		153,846 +45.9% 3.25 US$500,000
2021-04-29 2020-05-22 S Sale
3.1
Litchman Manuel MD

President and CEO

Executive Director
8,348 -1.0%
3.04
US$25,378 		8,348 -1.0% 3.04 US$25,378
2021-04-29 2020-05-22 S Sale
3.1
Litchman Manuel MD

President and CEO

Executive Director
4,025 -0.5%
3.04
US$12,236 		4,025 -0.5% 3.04 US$12,236
2021-04-16 2020-05-22 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
880 -0.6%
3.04
US$2,675 		880 -0.6% 3.04 US$2,675
2020-05-22 2020-05-21 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
90,000 +36.7%
3.13
US$281,700 		90,000 +36.7% 3.13 US$281,700
2020-05-22 2020-05-14 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
90,000 +58.1%
2.79
US$251,100 		90,000 +58.1% 2.79 US$251,100
2021-04-16 2020-03-31 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
3,033 -2.1%
2.64
US$8,007 		3,033 -2.1% 2.64 US$8,007
2021-04-16 2019-12-06 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
6,144 -4.0%
3.69
US$22,671 		6,144 -4.0% 3.69 US$22,671
2018-12-18 2018-12-10 B Purchase Litchman Manuel MD

President and CEO

Executive Director
8,000 +40.0%
3.35
US$26,805 		8,000 +40.0% 3.35 US$26,805
2018-12-18 2018-12-04 B Purchase Litchman Manuel MD

President and CEO

Executive Director
7,500 +60.0%
3.60
US$27,000 		7,500 +60.0% 3.60 US$27,000
2018-12-18 2018-11-26 B Purchase Litchman Manuel MD

President and CEO

Executive Director
5,000 +66.7%
3.87
US$19,354 		5,000 +66.7% 3.87 US$19,354
2018-12-07 2018-11-23 B Purchase Herskowitz Neil Non-Executive Director
1,000 +1.4%
3.96
US$3,960 		1,000 +1.4% 3.96 US$3,960
2018-12-18 2018-11-21 B Purchase Litchman Manuel MD

President and CEO

Executive Director
5,000 +200.0%
4.21
US$21,048 		5,000 +200.0% 4.21 US$21,048
2018-12-18 2018-11-20 B Purchase Litchman Manuel MD

President and CEO

Executive Director
2,500 +inf%
3.89
US$9,720 		2,500 +inf% 3.89 US$9,720
2018-12-03 2018-11-20 B Purchase Achenbach Brian

VP, Fin. & Corp. Controller

Officer
500 +0.9%
3.87
US$1,937 		500 +0.9% 3.87 US$1,937
2018-12-03 2018-11-19 B Purchase Achenbach Brian

VP, Fin. & Corp. Controller

Officer
1,000 +1.8%
4.25
US$4,250 		1,000 +1.8% 4.25 US$4,250
2018-12-03 2018-11-16 B Purchase Achenbach Brian

VP, Fin. & Corp. Controller

Officer
1,000 +1.8%
4.31
US$4,310 		1,000 +1.8% 4.31 US$4,310
2018-11-05 2018-11-02 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
50,000 +250.0%
4.41
US$220,500 		50,000 +250.0% 4.41 US$220,500
Explore more

More insider trading research around Mustang Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America